| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Revenue | $16.28B | +9.1% |
| Cost of Revenue | $11.04B | +10.0% |
| Gross Profit | $5.24B | +7.3% |
| R&D Expense | $610.0M | -0.3% |
| SG&A Expense | $1.58B | +4.8% |
| Operating Income | $2.76B | +13.2% |
| Interest Expense | $66.0M | +17.9% |
| Pre-tax Income | $2.73B | +14.9% |
| Income Tax | $306.0M |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.09B | -9.6% |
| Accounts Receivable | $2.87B | -2.2% |
| Inventory | $2.68B | +6.6% |
| Current Assets | $7.27B | +0.1% |
| Total Assets | $20.78B | -3.2% |
| Current Liabilities | $4.63B | -0.5% |
| Long-term Debt | $3.29B | -8.3% |
| Line Item | 2022-09-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.47B | -7.8% |
| Capital Expenditures | $768.0M | +11.3% |
| Investing Cash Flow | -$878.0M | +15.3% |
| Financing Cash Flow | -$1.68B | -21.5% |
| Free Cash Flow | $1.70B | -14.4% |
| +148.8% |
| Net Income | $2.43B | +7.4% |
| EPS (Basic) | $7.52 | +9.8% |
| EPS (Diluted) | $7.47 | +10.0% |
| Total Liabilities |
| $9.88B |
| -7.7% |
| Stockholders' Equity | $10.80B | +1.6% |